Trade BioNTech ^BNTX

BNTX Stock News: BioNTech Announces Layoffs as Covid-19 Revenue Slides

Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts

BioNTech Earnings: Clinical Development on Track, Busy Schedule for the Remainder of the Year | Morningstar

Health Care Up After Earnings - Health Care Roundup | Morningstar

BioNTech Q1 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) Announces Earnings Results - Zolmax

BioNTech to cut up to 1,860 jobs as Covid jab sales drop

BioNTech (NASDAQ:BNTX) Posts Earnings Results, Beats Estimates By $0.26 EPS - Daily Political

BioNTech (BNTX) Is Down 7.5% After Tariff Jitters, Leadership Shifts And Cut Guidance Reset - Has The Bull Case Changed?

BioNTech Faces Tariff Risks And Leadership Shift As Oncology Plans Advance

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?

CureVac targets Moderna with 10-patent suit over Spikevax

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Tuesday

BioNTech SE Sponsored ADR $BNTX Shares Sold by Flossbach Von Storch SE

BioNTech (BNTX) - Research Analysts' Recent Ratings Updates - Daily Political

BioNTech Stock Forecast | Co-Founder Exit, 2026 Guidance Cut | Capital.com

HC Wainwright Reaffirms "Buy" Rating for BioNTech (NASDAQ:BNTX)

BNTX Reiterates by HC Wainwright & Co. -- Price Target Maintaine

CureVac sues Moderna for patent infringement over COVID-19 vaccines

BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models

Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock

Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer

BioNTech (BNTX) Price Target Raised Following Successful T-Pam Data

BioNTech (NASDAQ:BNTX) COO Sierk Poetting Sells 50,000 Shares - Daily Political

BioNTech (BNTX) Is Up 13.4% After Positive HER2 Endometrial Cancer Phase 2 Data Release

BNTX: Leadership Turnover And Weak COVID Outlook Will Pressure Future Expectations

BioNTech (BNTX) Gains Investor Interest Following Promising ASCO Presentation

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Recent Share Price Momentum

BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story

Lbp Am Sa Acquires 15,255 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech's (BNTX) Buy Rating Reiterated at Berenberg Bank - Daily Political

BioNTech (BNTX) Is Up 9.8% After Strong Phase 2 HER2 ADC Data - Has The Bull Case Changed?

Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $133.13 - Stock Observer

BioNTech (NASDAQ:BNTX) Earns "Buy" Rating from Berenberg Bank - Stock Observer

A Look At BioNTech (BNTX) Valuation After Positive Phase 2 HER2 Endometrial Cancer Data

BioNTech announce Phase 2 cohort of BNT323 met primary efficacy endpoint | Markets Insider

BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer | Taiwan News | Apr. 11, 2026 19:00

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Recommendation of "Moderate Buy" by Analysts

BioNTech (NASDAQ:BNTX) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Aberdeen Group plc Lowers Stock Position in BioNTech SE Sponsored ADR $BNTX

How The BioNTech (BNTX) Story Is Shifting With New Leadership And Post COVID Pipeline Bets

Is BioNTech (BNTX) Quietly Rewriting Its Investment Story Around Oncology Beyond COVID Vaccines?